Skip to main content
. 2021 Nov 28;26(23):7213. doi: 10.3390/molecules26237213

Figure 3.

Figure 3

Influence of SGLT2 inhibitors on unrestrained activation of mTOR (mechanistic/mammalian target of rapamycin). AMPK-AMP-activated protein kinase, SIRT-Sirtuin.